Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Stem Cell Manufacturing Market: By Products, By Therapeutic Application, By End Users and Geography
Stem Cell Manufacturing Market: By Products, By Therapeutic Application, By End Users and Geography
Stem Cell Manufacturing Market size was valued at US$ 12,849.3 million in 2023, and is poised to grow at at a 7.8% CAGR from 2024 to 2030. The market is a fast-growing sector within the field of Biopharmaceuticals, encompasses the production, development, and commercialization of stem cells for various applications, including regenerative medicine, drug discovery, and disease modelling. The growing demand for stem cell-based therapies coupled with increasing prevalence of chronic diseases such as cancer, diabetes, arthritis and so on primarily drives the market. For instance, according to Globocan 2020, more than 19 million new cancer cases and approximately 10 million deaths were reported in 2020. This certainly expands the development of innovative stem cell therapies.
However, regulatory challenges and ethical concerns pose challenges for the growth of the market. Moreover, emerging applications in personalised medicine and the development of advanced yet cost-effective stem cell manufacturing technologies present potential opportunities for augmentation of the market. Increased collaboration and development of novel techniques have accelerated the growth of the market. For example, in January 2022, Century Therapeutics, a leading iPSC-derived allogeneic cell therapy platform and Bristol Myers Squibb, expertise in cell therapy and oncology drug development, announced a strategic collaboration to develop induced pluripotent stem cell (“iPSC”) derived, engineered natural killer cell (“iNK”) and / or T cell (“iT”) programs for hematologic malignancies and solid tumors.
Study Period
2024-2030Base Year
2023CAGR
7.8%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The growing prevalence of chronic diseases and the need for effective treatment options have fueled the demand for regenerative medicine. Stem cell-based therapies offer the potential for tissue repair and regeneration, driving the demand for stem cell manufacturing. Moreover, Advancements in stem cell manufacturing technologies, such as automated bioreactors, three-dimensional (3D) cell culture systems, scalable manufacturing platforms, and incorporation of machine learning technologies have improved the efficiency and scalability of stem cell production. These advancements have contributed to the growth of the stem cell manufacturing market.
Stem cell manufacturing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America holds a significant share in the market due to presence of well-established biotechnology and pharmaceutical industries, and cutting-edge medical infrastructure, and major expenditures in stem cell research. The United States is the largest market in the region, driven by encouraging government initiatives, favorable regulatory environments, and robust research and development activities in stem cell manufacturing. In Asia pacific region, countries such as China, Japan, and India are witnessing substantial investments in regenerative medicine and stem cell research. The region's large patient population, increasing healthcare infrastructure and supportive government initiatives are driving the market growth.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 12,849.3 million |
|
Market CAGR |
7.8% |
|
By Product |
|
|
By Therapeutic Application |
|
|
By End User |
|
Download Free Sample Report
Stem cell manufacturing market size was valued at US$ 12,849.3 million in 2023, growing at a 7.8% CAGR from 2024 to 2030.
Integration of gene editing technologies, rising need for personalized stem cell therapies, and collaboration with academic institutions and research organizations are some of the potential opportunities for companies to enhance their revenue over the forecast years.
Growing trend towards automation and advanced bioprocessing technologies, expansion of 3d bioprinting applications, and development of scalable manufacturing platforms are some of the major trends in the infectious disease diagnosis market
Lonza Group Ltd., Merck KGaA, Stemedica Cell Technologies, Alkem Labs, Stempeutics, GE Healthcare, Century Therapeutics, STEMCELL Technologies Inc., Fujifilm Holdings Corporation, Cellular Dynamics International, Takara Bio Inc., Osiris Therapeutics, Inc., Becton, Dickinson and Company, Editas Medicine, Inc, Genscript Biotech Corporation, Eurofins Scientific, Perkinelmer, Inc., Thermo Fisher Scientific, Inc, Danaher Corporation, Aglient Technologies, Inc., Mission Bio, Bio-Rad Laboratoies, Inc., Qiagen N.V. are some of the key players in the stem cell manufacturing market.
| 1.Executive Summary |
| 2.Global Stem Cell Manufacturing Market Introduction |
| 2.1.Global Stem Cell Manufacturing Market - Taxonomy |
| 2.2.Global Stem Cell Manufacturing Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Therapeutic Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Stem Cell Manufacturing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Stem Cell Manufacturing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Stem Cell Manufacturing Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Stem Cell lines |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Culture Media |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Kits and Reagents, |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Instruments |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Services |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6.Global Stem Cell Manufacturing Market By Therapeutic Application , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Regenerative Medicines |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Oncology |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Neurology |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Dermatology |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Cardiology |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Hematology |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Orthopedics |
| 6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 6.8. Others |
| 6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.8.3. Market Opportunity Analysis |
| 7.Global Stem Cell Manufacturing Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Biotechnology and Pharmaceutical Industries |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Tissue and Cell Banks |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Hospital |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Academic and Research Organizations |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Contract Research Organizations |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Others |
| 7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 8.Global Stem Cell Manufacturing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Stem Cell Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Stem Cell lines |
| 9.1.2.Culture Media |
| 9.1.3.Kits and Reagents, |
| 9.1.4.Instruments |
| 9.1.5.Services |
| 9.2. Therapeutic Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Regenerative Medicines |
| 9.2.2.Oncology |
| 9.2.3.Neurology |
| 9.2.4.Dermatology |
| 9.2.5.Cardiology |
| 9.2.6.Hematology |
| 9.2.7.Orthopedics |
| 9.2.8.Others |
| 9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Biotechnology and Pharmaceutical Industries |
| 9.3.2.Tissue and Cell Banks |
| 9.3.3.Hospital |
| 9.3.4.Academic and Research Organizations |
| 9.3.5.Contract Research Organizations |
| 9.3.6.Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Stem Cell Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Stem Cell lines |
| 10.1.2.Culture Media |
| 10.1.3.Kits and Reagents, |
| 10.1.4.Instruments |
| 10.1.5.Services |
| 10.2. Therapeutic Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Regenerative Medicines |
| 10.2.2.Oncology |
| 10.2.3.Neurology |
| 10.2.4.Dermatology |
| 10.2.5.Cardiology |
| 10.2.6.Hematology |
| 10.2.7.Orthopedics |
| 10.2.8.Others |
| 10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Biotechnology and Pharmaceutical Industries |
| 10.3.2.Tissue and Cell Banks |
| 10.3.3.Hospital |
| 10.3.4.Academic and Research Organizations |
| 10.3.5.Contract Research Organizations |
| 10.3.6.Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Stem Cell Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Stem Cell lines |
| 11.1.2.Culture Media |
| 11.1.3.Kits and Reagents, |
| 11.1.4.Instruments |
| 11.1.5.Services |
| 11.2. Therapeutic Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Regenerative Medicines |
| 11.2.2.Oncology |
| 11.2.3.Neurology |
| 11.2.4.Dermatology |
| 11.2.5.Cardiology |
| 11.2.6.Hematology |
| 11.2.7.Orthopedics |
| 11.2.8.Others |
| 11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Biotechnology and Pharmaceutical Industries |
| 11.3.2.Tissue and Cell Banks |
| 11.3.3.Hospital |
| 11.3.4.Academic and Research Organizations |
| 11.3.5.Contract Research Organizations |
| 11.3.6.Others |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Stem Cell Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Stem Cell lines |
| 12.1.2.Culture Media |
| 12.1.3.Kits and Reagents, |
| 12.1.4.Instruments |
| 12.1.5.Services |
| 12.2. Therapeutic Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Regenerative Medicines |
| 12.2.2.Oncology |
| 12.2.3.Neurology |
| 12.2.4.Dermatology |
| 12.2.5.Cardiology |
| 12.2.6.Hematology |
| 12.2.7.Orthopedics |
| 12.2.8.Others |
| 12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Biotechnology and Pharmaceutical Industries |
| 12.3.2.Tissue and Cell Banks |
| 12.3.3.Hospital |
| 12.3.4.Academic and Research Organizations |
| 12.3.5.Contract Research Organizations |
| 12.3.6.Others |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Stem Cell Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Stem Cell lines |
| 13.1.2.Culture Media |
| 13.1.3.Kits and Reagents, |
| 13.1.4.Instruments |
| 13.1.5.Services |
| 13.2. Therapeutic Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Regenerative Medicines |
| 13.2.2.Oncology |
| 13.2.3.Neurology |
| 13.2.4.Dermatology |
| 13.2.5.Cardiology |
| 13.2.6.Hematology |
| 13.2.7.Orthopedics |
| 13.2.8.Others |
| 13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Biotechnology and Pharmaceutical Industries |
| 13.3.2.Tissue and Cell Banks |
| 13.3.3.Hospital |
| 13.3.4.Academic and Research Organizations |
| 13.3.5.Contract Research Organizations |
| 13.3.6.Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Lonza Group Ltd. |
| 14.2.2.Merck KGaA |
| 14.2.3.Stemedica Cell Technologies |
| 14.2.4.Alkem Labs |
| 14.2.5.Stempeutics |
| 14.2.6.GE Healthcare |
| 14.2.7.Century Therapeutics |
| 14.2.8.STEMCELL Technologies Inc. |
| 14.2.9.Fujifilm Holdings Corporation |
| 14.2.10.Cellular Dynamics International |
| 14.2.11.Takara Bio Inc. |
| 14.2.12.Osiris Therapeutics, Inc. |
| 14.2.13.Becton, Dickinson and Company |
| 14.2.14.Editas Medicine, Inc |
| 14.2.15.Genscript Biotech Corporation |
| 14.2.16.Eurofins Scientific |
| 14.2.17.Perkinelmer, Inc. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.